This week’s Petri Dish roundup covers yet more biotech layoffs, introduces Flagship Pioneering’s new managing partner and explains Editas Medicine’s sale of some Cas9 license fees.
Indigo Ag has hired a new chief financial officer, while a biotech developing a potential epilepsy drug got a Series A as ...
Bright Minds Biosciences, which until this week had a lightly traded stock that traded at just over $1, tumbled in premarket trade on Wednesday following a meteoric rise. Bright Minds shares DRUG ...
Allison DeAngelis, who covers biotech startups and venture capital, is also the author of STAT’s annual report “Ranking Biotech’s Top Venture Capital Firms.” Biotech investors have been ...
Cell therapy biotech Tolerance Bio has unveiled with $17.2 million and a mission of targeting immune diseases by stretching and saving the function of a key organ. The Philadelphia biotech’s ...
Nov. 4, 2024 — Researchers used genomics to investigate the genetic changes causing resistance to transgenic crops in field populations of the corn earworm, also known as cotton bollworm or ...
Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...
Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...
The United States's dominance in biotech innovation is crucial to our national interests and global security. In recent years, China has quickly become a powerhouse, bolstered by its biotech ...
Fidelity Select Biotechnology Portfolio earns an Above Average Process Pillar rating. The leading factor in the rating is its parent firm's excellent long-term risk-adjusted performance ...
Apr. 23, 2024 — Researchers describe the steps they took to manipulate DNA and proteins -- essential building blocks of life -- to create cells that look and act like cells from the body. This ...